PROVAYBLUE (American Regent)
Welcome to the PulseAid listing for the PROVAYBLUE drug offered from American Regent. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | American Regent |
| NON-PROPRIETARY NAME: | methylene blue |
| SUBSTANCE NAME: | METHYLENE BLUE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
PROVAYBLUE HUMAN PRESCRIPTION DRUG Details:
| Item Description | PROVAYBLUE from American Regent |
| LABELER NAME: | American Regent |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0517-0374_3106267e-fe42-0ef9-e054-00144ff8d46c |
| PRODUCT NDC: | 0517-0374 |
| APPLICATION NUMBER: | NDA204630 |
Other METHYLENE BLUE Pharmaceutical Manufacturers / Labelers:
